Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial

Blood blood.2025031313.

https://doi.org/10.1182/blood.2025031313

Published: 2025

Includes: Supplemental data

Journal Articles

A mixed methods evaluation of American society of Hematology's (ASH) clinical guidelines

Marshall Cheney, Austin Smith, Toby Clampitt, Julia Naifeh, Sara Vesely, Sanober Nusrat, Mohamad Khawandanah, Jennifer Holter-Chakrabarty, Patrick Irelan, Deirdra Terrell

Blood (2025) 146 (Supplement 1): 2873.

https://doi.org/10.1182/blood-2025-2873

Published: 2025

Journal Articles

Orca-T improves chronic graph-versus-host disease free in patients with a broad range of demographic and clinical variables: Results of randomized, Phase 3 trial

Blood (2025) 146 (Supplement 1): 2477.

https://doi.org/10.1182/blood-2025-2477

Published: 2025

Journal Articles

The impact of immune thrombocytopenia on oral health: Let's talk

Rashmi Jaggad, Shirley James, Honieh Sowdagar, Ruby Shrestha, Sandhya Panch, Amanda Grimes, Camila Masias, Sara Vesely, Sanober Nusrat, Mohamad Khawandanah, Jennifer Holter-Chakrabarty, James Bussel, Deirdra Terrell

Blood (2025) 146 (Supplement 1): 6257.

https://doi.org/10.1182/blood-2025-6257

Published: 2025

Journal Articles

Germline genetic variants and post-HCT cytokine/chemokine milieu may identify those at higher risk of primary graft failure after allogeneic hematopoietic cell transplantation, a blood and marrow transplant clinical trials network (BMT CTN) study

Kirsten Williams, Jennifer Holter-Chakrabarty, Sara Vesely, Marie Gordon, Ashwin Koppayi, Yvonne Suessmuth, Iskra Pusic, John McCarty, Philip McCarthy, Asad Bashey, Gregory Yanik, Michelle Schoettler, Valerie Stewart, Sarita Layton, Stephen Spellman, Wael Saber, Christopher Porter, Lucy Godley

Blood (2025) 146 (Supplement 1): 4209.

https://doi.org/10.1182/blood-2025-4209

Published: 2025

Journal Articles

Observational comparison of orca-T to registry-based post-transplant cyclophosphamide patients using matched unrelated donors

Blood (2025) 146 (Supplement 1): 6029.

https://doi.org/10.1182/blood-2025-6029

Published: 2025

Journal Articles

Pre-CAR-T pulmonary function test and respiratory comorbidities have limited predictive value for survival, toxicities, and respiratory complications

Yuanli Lei, Muhammad Atif Khan, Aqsa Ashraf, Noha Soror, Muhammad Salman Faisal, Jennifer Holter-Chakrabarty, Adam Asch, Forat Lutfi, Rachel Dileo, Sami Ibrahimi, Manu Pandey, Mohamad Khawandanah, Silas Day, Huimin Wu, Prerna Mewawalla, Nausheen Ahmed, Taha Al-Juhaishi

Blood (2025) 146 (Supplement 1): 2373.

https://doi.org/10.1182/blood-2025-2373

Published: 2025

Journal Articles

Outpatient administration of idecabtagene vicleucel: Predictors of hospitalization and impact on survival outcomes

Aqsa Ashraf, Noha Soror, Ayesha Aijaz, Muhammad Salman Faisal, Zimu Gong, Manu Pandey, Sami Ibrahimi, Adam Asch, Mohamad Khawandanah, Jennifer Holter-Chakrabarty, Silas Day, Michael Machiorlatti, Taha Al-Juhaishi

Blood (2025) 146 (Supplement 1): 7598.

https://doi.org/10.1182/blood-2025-7598

Published: 2025

Journal Articles

Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients

Blood (2024) 144 (Supplement 1): 694.

https://doi.org/10.1182/blood-2024-205917

Published: 2024

Journal Articles

MER Signaling Axis: A Novel Therapeutic Target in Chronic Lymphocytic Leukemia

Mariana T. Mendez, Asish K Ghosh, Murali Mamidi, Sara K. Vesely, Jennifer Holter-Chakrabarty

Blood (2022) 140 (Supplement 1): 6990.

https://doi.org/10.1182/blood-2022-158766

Published: 2022

Journal Articles

Novel Home-Based Transfusion Model of Palliative Care in Malignant Hematology

Blood (2022) 140 (Supplement 1): 11024–11025.

https://doi.org/10.1182/blood-2022-162527

Published: 2022

Journal Articles

Successful Development of an Outpatient Chimeric Antigen Receptor (CAR) T Cell Therapy Program

Azra Borogovac, Amany R. Keruakous, Michelle Bycko, Jennifer Holter Chakrabarty, Sami Ibrahimi, Mohamad O. Khawandanah, George B. Selby, Carrie Yuen, Sarah A. Schmidt, Taha Al-Juhaishi, Matthew Wieduwilt, Adam S. Asch

Blood (2021) 138 (Supplement 1): 4821.

https://doi.org/10.1182/blood-2021-153457

Published: 2021

Journal Articles

Outcomes of Allogeneic Stem Cell Transplantation with Individualized Dosing of Antithymocyte Globulin

Amany R. Keruakous, MD, George Selby, MD, Sarah A. Schmidt, PharmD, Jennifer Holter-Chakrabarty, MD, Mohamad O. Khawandanah, MBBS, Jennifer Steward, PharmD, Silas Day, Carrie Yuen, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-141350

Published: 2020

Journal Articles

Early Assessment of Treatment Response in Acute Myeloid Leukemia Using FLT PET/CT Imaging: A Trial of the ECOG-ACRIN Cancer Research Group (EAI141)

Robert Jeraj, PhD, Fenghai Duan, PhD, Ryan J. Mattison, MD, Lale Kostakoglu, MD MPH, Daniel A. Arber, MD, Elisabeth Paietta, PhD, Justin Romanoff, AM, Jennifer Holter-Chakrabarty, MD, Charles Arnold, MD, Stephen A. Strickland, MD, Jennifer Whisenant, PhD, Barry Alan Siegel, MD, Geoffrey L Uy, MD, Kebede H. Begna, MD, Gregory Wiseman, MD, Aric C. Hall, MD, Scott Perlman, MD, Mark Litzow, MD, David Mankoff, MD PhD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-136721

Published: 2020

Journal Articles

Hypomethylating Agent Maintenance Therapy after Allogeneic Stem Cell Transplant Improves Transplant Outcome in High Risk Acute Myelogenous Leukemia

Amany R. Keruakous, MD, Jennifer Holter Chakrabarty, MD, Sarah Ann Schmidt, PharmD, Mohamad O. Khawandanah, MBBS, George Selby, MD, Carrie Yuen, MD

Blood (2019) 134 (Supplement_1): 3297.

https://doi.org/10.1182/blood-2019-128316

Published: 2019

Journal Articles

Tyrosine Kinase Inhibitors with or without Donor Lymphocyte Infusion Continue to Provide Long-Term Survival after Relapse of Chronic Myeloid Leukemia Following Hematopoietic Cell Transplantation

Sarah Ann Schmidt, PharmD, Jennifer Holter Chakrabarty, MD, Ying Liu, PhD, Zhen-Huan Hu, MPH, Kirsten M. Williams, MD, Edwin P. Alyea, III, MD, Uday Popat, MD, Ronald Sobecks, MD, Bart L Scott, MD, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 704.

https://doi.org/10.1182/blood-2018-99-118918

Published: 2018

Journal Articles

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection

Blood (2015) 126 (18): 2153–2161.

https://doi.org/10.1182/blood-2015-05-645986

Published: 2015

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial

A mixed methods evaluation of American society of Hematology's (ASH) clinical guidelines

Orca-T improves chronic graph-versus-host disease free in patients with a broad range of demographic and clinical variables: Results of randomized, Phase 3 trial

The impact of immune thrombocytopenia on oral health: Let's talk

Germline genetic variants and post-HCT cytokine/chemokine milieu may identify those at higher risk of primary graft failure after allogeneic hematopoietic cell transplantation, a blood and marrow transplant clinical trials network (BMT CTN) study

Observational comparison of orca-T to registry-based post-transplant cyclophosphamide patients using matched unrelated donors

Pre-CAR-T pulmonary function test and respiratory comorbidities have limited predictive value for survival, toxicities, and respiratory complications

Outpatient administration of idecabtagene vicleucel: Predictors of hospitalization and impact on survival outcomes

Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients

MER Signaling Axis: A Novel Therapeutic Target in Chronic Lymphocytic Leukemia

Novel Home-Based Transfusion Model of Palliative Care in Malignant Hematology

Successful Development of an Outpatient Chimeric Antigen Receptor (CAR) T Cell Therapy Program

Outcomes of Allogeneic Stem Cell Transplantation with Individualized Dosing of Antithymocyte Globulin

Early Assessment of Treatment Response in Acute Myeloid Leukemia Using FLT PET/CT Imaging: A Trial of the ECOG-ACRIN Cancer Research Group (EAI141)

Hypomethylating Agent Maintenance Therapy after Allogeneic Stem Cell Transplant Improves Transplant Outcome in High Risk Acute Myelogenous Leukemia

Tyrosine Kinase Inhibitors with or without Donor Lymphocyte Infusion Continue to Provide Long-Term Survival after Relapse of Chronic Myeloid Leukemia Following Hematopoietic Cell Transplantation

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only